TITRATE research trial-RA participants required - NRAS

NRAS

37,263 members46,132 posts

TITRATE research trial-RA participants required

11 Replies

NRAS are pleased to support this important trial

TITRATE Trial: To compare intensive management with standard care in patients with Rheumatoid Arthritis (RA) with intermediate disease activity.

Summary: The National Institute for Health Research (NIHR) is funding a pragmatic randomised controlled trial to compare intensive management with standard care in patients with Rheumatoid Arthritis showing intermediate disease activity (DAS 28-ESR 3.2-5.1). The trial takes place in different hospitals across England and is led by Professor David Scott at King’s College London and King’s College NHS Foundation Trust, London.

The trial has two arms to which patients are randomly allocated: (i) standard care and (ii) intensive management. The first aim of the study is to achieve disappearance of signs and symptoms of RA, e.g. pain, fatigue, mobility, measured by DAS28-ESR (less than 2.6) at 12 months. The secondary aims are to: (i) reduce disability, (ii) improve quality of life and (iii) show that intensive management is acceptable to patients. We will also find out the cost-effectiveness of such an approach compared with standard care.

Assessment: Patients will be screened first to see if they are eligible for the trial (based on certain criteria), and further assessments will take place at the beginning of the trial, at 6 and 12 months. These include completion of a variety of questionnaires, blood tests and x-rays of hands and feet.

Intensive Management Intervention will involve monthly reviews in the outpatient clinic where patients’ intensive treatment will be (i) reviewed and medication adjusted by a rheumatologist and (ii) supportive non-drug advice and guidance will be provided by nurses to meet each patient’s individual needs. This approach will include goal setting, skills teaching, e.g. management of pain, fatigue and physical activity, based on a specifically developed study manual. The nurses will have undergone a bespoke training to deliver this additional support.

Duration of treatment: 12 months.

Safety: Patients will be regularly monitored via blood tests.

If you need any further information about the TITRATE trial, or are interested in participating, please visit the TITRATE website (titrate.org.uk) for a full list of participating hospitals.

Alternatively, please contact the Trial Manager, Dr Naomi Martin, on 0207 848 5204 or titrate@kcl.ac.uk.

Please note that you will only be able to participate if the hospital where you are receiving your specialist treatment is involved in the trial.to see the list of participating hospitals visit the titrate website or

nras.org.uk/titrate-trial

Read more about...
11 Replies
nomoreheels profile image
nomoreheels

I would have jumped at the chance to be considered, but save for 3 (out of 18) participating hospitals/Trusts all are way south of where I live/attend. Seems the hospitals, if they were invited to partake, think RD doesn't affect anyone in the North West, or is it another case of the lead team think not much exists north of Watford?!

babssara profile image
babssara

Not a single one in the North west. Manchester area. Do we know why? Can they not get Pennine Acute to participate? Feel as though being excluded! x

Grumpy_Al profile image
Grumpy_Al in reply tobabssara

I'm on the titrate trial through Leighton Hospital I Crewe. I think there 4 of us on the trial so it's worth asking your RA tam at your hospital if you can participate.

in reply tobabssara

More units are being added all the time, I've just been in contact with the research lead. if you are interested in being part of this trial make contact with them and they can let you know if there is a unit near you participating. titrate.org.uk

babssara profile image
babssara in reply to

Thanks Clare. I would be interested so will be in touch with the unit. Thanks for finding this information for me. x

Jayne18 profile image
Jayne18

Hi

I would have been interested to take part too, as yesterday my Mtx therapy has been stopped and I am awaiting my Cons go ahead for new therapy to commence - great timing wrong hospital 👎😞

Typically!

J x

This is fairly early on in the trial so more units may be added to those currently taking part. I would hazard a guess that it is down to resource and capacity to take on such a trial.If the rheumatology unit are not fully staffed it would make running the trial very difficult. I shall give your feedback to the research leads, or you can email them directly at titrate@kcl.ac.uk

nomoreheels profile image
nomoreheels in reply to

Thanks for that Clare. The staffing issue may be the problem at my hospital as my Consultant's been on extended leave since the beginning of the year, though at least one locum has been taken on. I have an appointment next month so will question if it's a future possibility & see how the land lies before contacting.

in reply tonomoreheels

Latest but not exhaustive list of participating hospitals see below

King's College Hospital NHS Foundation Trust

Lewisham and Greenwich NHS Trust

Maidstone and Tunbridge Wells NHS Trust

Portsmouth Hospitals NHS Trust

Sheffield Teaching Hospitals NHS Foundation Trust

Croydon Health Services NHS Trust

Royal Devon & Exeter NHS Foundation Trust

RNOH NHS Trust

Guy's & St Thomas' NHS Foundation Trust

Gateshead Health NHS Foundation Trust

The Royal Bournemouth & Christchurch NHS Foundation Trust

Royal Cornwall Hospitals NHS Trust

Northumbria Healthcare NHS Foundation Trust

Plymouth Hospitals NHS Trust

Derby Hospitals NHS Foundation Trust

South Devon Healthcare NHS Foundation Trust

West Suffolk NHS Foundation Trust

University College London Hospitals NHS Foundation Trust

Great Western Hospitals NHS Foundation Trust

The Newcastle Upon Tyne Hospitals NHS Foundation Trust

Ashford and St Peter's NHS Foundation Trust

Lancashire Care NHS Foundation Trust

Northampton General Hospital NHS Trust

South Tees Hospitals NHS Foundation Trust

St George's University Hospitals NHS Foundation Trust

Mid Cheshire Hospitals NHS Foundation Trust

Nottingham University Hospitals NHS Trust

Wrightington, Wigan and Leigh NHS Foundation Trust

The Dudley Group Group NHS Foundation Trust

University Hospitals Coventry and Warwickshire NHS Trust

East Kent Hospitals University NHS Foundation Trust

nomoreheels profile image
nomoreheels in reply to

My hospital's trust not included unfortunately. Thanks for your continued help though.

digger1 profile image
digger1

I wish that they would do trials like this in Scotland 😡

Not what you're looking for?

You may also like...

SWITCH - pioneering trial for rheumatoid arthritis sufferers

A new drug trial has been launched in a number of NHS hospitals across the UK for patients whose...

Research

I received the information regarding the research I have been recommended. Read there are 2 arms...
Matilda_1922 profile image

Prevention of RA...is it possible? Urgent request for participants to attend a London focus group Tuesday 26th February.

NRAS is supporting a clinical study being carried out by King’s College London and Guy’s & St...

Covid trial

An important trial will test how to boost Covid jab protection in vulnerable patients whose immune...
Bethany02 profile image

?RA

Hi. Newbie here. I've got a rheumatology appointment on Friday as GP suspects I have some sort of...
Mags22 profile image

Moderation team

See all
KateL-NRAS profile image
KateL-NRASAdministrator
Donagh-NRAS profile image
Donagh-NRASAdministrator
Nicola-NRAS profile image
Nicola-NRASAdministrator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.